ASX 200 Market Leaders in 2026

Strong project progress, strategic investments and market expansion initiatives have helped SRL, 4DX and MI6 emerge as standout ASX 200 performers

Sunrise Energy Metals Limited (ASX: SRL)

on 15 June 2026, announced a proposed US$5 million investment in Agni Semiconductor LLC, a US-based developer of advanced non-volatile memory and AI compute-in-memory technology using aluminium scandium nitride (AlScN). The investment would represent half of Agni’s US$10 million Seed Round and could provide Sunrise with about 18% ownership on a fully diluted basis.
The deal includes governance rights such as board representation, observer access, future participation rights and a pathway to increase ownership. It supports Sunrise’s strategy of expanding into downstream scandium-related technologies beyond its mining operations.

Agni plans to use the funds for product development, foundry qualification, prototype programs, compute-in-memory designs and team growth over the next 30 months. Sunrise believes wider use of AlScN in memory and AI hardware could create an important future source of demand for high-purity scandium from its Syerston Scandium Project.

4DMedical Limited (ASX: 4DX)

on 29 May 2026, secured a commercial agreement with SimonMed Imaging, bringing CT:VQ and LDAf into more than 170 outpatient imaging centres across 10 U.S. states. The partnership also supports development of reimbursement evidence with public and private payors.

On 1 June 2026, the company announced the acquisition of Austria-based contextflow, establishing an immediate European platform. The deal provides an experienced local team, commercial and regulatory infrastructure, insurance reimbursement contracts in Germany, a lung cancer screening solution, and access to a respiratory imaging market valued at US$1.5–2 billion.

On 2 June 2026, 4DMedical launched the CLEAR clinical evidence program to accelerate CT:VQ adoption in acute pulmonary embolism. The study will compare CT:VQ with CTPA across multiple sites and countries, with Mass General Brigham affiliated hospitals acting as the lead site.
CLEAR expands CT:VQ beyond the existing nuclear VQ market into a much larger PE opportunity, increasing the obtainable U.S. market to about US$3 billion.

Minerals 260 Limited (ASX: MI6)

on 15 June 2026, started early construction and development work at its fully owned 4.5Moz Bullabulling Gold Project in Western Australia. This marks a main step toward starting plant construction in the first half of 2027 with first gold production targeted for the fourth quarter of 2028. Work is underway on village construction, water infrastructure and grade control drilling. MI6 also received approval for the Mining Development and Closure Proposal and village construction works in May 2026, whereas other key project approvals continue to advance.

The development activities include a fixed price contract signed in April 2026 for a 400 person accommodation village. Site preparation, earthworks and facility manufacturing have commenced with operations expected in Q1 2027. Water exploration has identified several potential sources and drilling plus bore installation has begun. The maiden Ore Reserve and Pre-Feasibility Study remain scheduled for July 2026, followed by an updated Mineral Resource Estimate in August 2026.

(Source: Company Report)